Skip to main content
Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.300
+0.090 (7.44%)
At close: Jun 2, 2025, 4:00 PM
1.320
+0.020 (1.54%)
After-hours: Jun 2, 2025, 7:26 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Cellular Immunotherapies
63.53M
Log In
Log In
Log In
Log In
Upgrade
Cellular Immunotherapies Growth
-34.03%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
63.53M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-34.03%
Log In
Log In
Log In
Log In
Upgrade